Prevalence of perennial severe allergic asthma in Italy and effectiveness of omalizumab in its management: PROXIMA – an observational, 2 phase, patient reported outcomes study
Research Giorgio Walter Canonica1, Marta Bartezaghi2, Raffaele Marino2 and Laura Rigoni2* Clinical and Molecular Allergy 2015, 13:10 doi:10.1186/s12948-015-0019-7 Published: 7 July 2015 Abstract Background We designed the PROXIMA study (Patient-Reported Outcomes and Xolair ® In the Management of Asthma)…